Engineered guide RNA for increasing efficiency of CRISPR / Cas12f1 system, and use of same

AU2026210687A1Pending Publication Date: 2026-08-20GENKORE INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026210687
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-07-28
Publication Date
2026-08-20

Smart Images

  • Figure 00000136_0000
    Figure 00000136_0000
  • Figure 00000137_0000
    Figure 00000137_0000
  • Figure 00000138_0000
    Figure 00000138_0000
Patent Text Reader

Abstract

In the present disclosure, there is provided an engineered Cas12f1 guide RNA for increasing intracellular gene editing activity of a CRISPR / Cas12f1 system by overcoming limitations of the prior art. The engineered Cas12f1 guide RNA is an engineered form of a naturally occurring guide RNA whose structure is partially modified. In addition, the engineered Cas12f1 guide RNA is characterized in that at least a portion of the scaffold region, which serves to interact with the Cas12f1 protein, is modified. The engineered scaffold region is characterized in that it is different from a scaffold region of a naturally occurring guide RNA. 20 26 21 06 87 28 J ul 2 02 6 2 0 2 6 2 1 0 6 8 7 2 8 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art